Misclassification of overdose events in the X:BOT study

Commentary on Ajazi et al (2021) Re-analysis of the X

(2021) Joshua D. Lee et al.   Journal of Addiction Medicine

Revisiting the X

(2021) Elizabeth M. Ajazi et al.   Journal of Addiction Medicine

Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018

(2020) Priya Jain et al.   DRUG SAFETY

Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence

(2018) Roxanne Saucier et al.   DRUG SAFETY

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

(2018) Joshua D Lee et al.   LANCET

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence

(2017) Lars Tanum et al.   JAMA Psychiatry

Challenges in Coding Adverse Events in Clinical Trials: A Systematic Review

(2012) Jeppe Bennekou Schroll et al.   PLoS One

Concerns about injectable naltrexone for opioid dependence

(2011) Daniel Wolfe et al.   LANCET